2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO44] Mini-Oral Session 44　Lung Cancer / Thoracic Cancer 7（ICI）
【E】

Sat. Feb 19, 2022 9:55 AM - 10:45 AM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Kyoichi Kaira（Department of Respiratory Medicine, Saitama Medical University），Shunichi Sugawara（Department of Pulmonary Medicine, Sendai Kousei Hospital）

[MO44-3] Nivolumab versus Pembrolizumab in previously-treated advanced NSCLC patients: Propensity-Matched Real World Analysis

○Masahiro Torasawa1,2, Tatsuya Yoshida1,3, Shigehiro Yagisita4, Yukiko Shimoda1, Yuki Takeyasu1, Masayuki Shirasawa1, Yuji Matsumoto1, Ken Masuda1, Yuki Shinno1, Yusuke Okuma1, Yasushi Goto1, Hidehito Horinouchi1, Noboru Yamamoto1,3, Yuichiro Ohe1 (1.Department of Thoracic Oncology, National Cancer Center Hospital, 2.Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 3.Department of Experimental Therapeutics, National Cancer Center Hospital, 4.Division of Molecular Pharmacology National Cancer Center Research Institute)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password